Dr. Reddy's Laboratories Limited (DRREDDY.NS)
INR 1116.65
(-0.32%)
INR 1116.65
(-0.32%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 95.87 Billion INR | -14.91% |
| 2022 | 117.61 Billion INR | 53.14% |
| 2021 | 76.8 Billion INR | 9.53% |
| 2020 | 70.11 Billion INR | 14.48% |
| 2019 | 61.24 Billion INR | -2.07% |
| 2018 | 62.54 Billion INR | -2.87% |
| 2017 | 64.38 Billion INR | -0.73% |
| 2016 | 64.85 Billion INR | 3.5% |
| 2015 | 62.66 Billion INR | 6.0% |
| 2014 | 59.11 Billion INR | 18.78% |
| 2013 | 49.76 Billion INR | 28.34% |
| 2012 | 38.77 Billion INR | 14.01% |
| 2011 | 34.01 Billion INR | 23.08% |
| 2010 | 27.63 Billion INR | 7.41% |
| 2009 | 25.72 Billion INR | 1.65% |
| 2008 | 25.31 Billion INR | 14.79% |
| 2007 | 22.05 Billion INR | 11.94% |
| 2006 | 19.69 Billion INR | 88.77% |
| 2005 | 10.43 Billion INR | -0.17% |
| 2004 | 10.45 Billion INR | 20.51% |
| 2003 | 8.67 Billion INR | 26.35% |
| 2002 | 6.86 Billion INR | 46.6% |
| 2001 | 4.68 Billion INR | 25.4% |
| 2000 | 3.73 Billion INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 26.68 Billion INR | -2.45% |
| 2024 Q2 | 30.27 Billion INR | 13.24% |
| 2023 Q4 | 27.35 Billion INR | 8.13% |
| 2023 Q2 | 22.88 Billion INR | 4.46% |
| 2023 Q1 | 21.9 Billion INR | -29.93% |
| 2023 Q3 | 25.29 Billion INR | 10.55% |
| 2023 FY | 100.07 Billion INR | -14.91% |
| 2022 Q1 | 13.81 Billion INR | -29.91% |
| 2022 FY | 117.61 Billion INR | 53.14% |
| 2022 Q4 | 31.26 Billion INR | 32.46% |
| 2022 Q3 | 23.6 Billion INR | 12.36% |
| 2022 Q2 | 21 Billion INR | 52.05% |
| 2021 Q1 | 19.12 Billion INR | 7.51% |
| 2021 Q2 | 19.8 Billion INR | 3.56% |
| 2021 FY | 76.8 Billion INR | 9.53% |
| 2021 Q3 | 19.35 Billion INR | -2.26% |
| 2021 Q4 | 19.7 Billion INR | 1.83% |
| 2020 Q2 | 17.31 Billion INR | 4.02% |
| 2020 Q4 | 17.78 Billion INR | -3.16% |
| 2020 FY | 70.11 Billion INR | 14.48% |
| 2020 Q3 | 18.36 Billion INR | 6.06% |
| 2020 Q1 | 16.64 Billion INR | 2.77% |
| 2019 Q4 | 16.19 Billion INR | -1.17% |
| 2019 FY | 61.24 Billion INR | -2.07% |
| 2019 Q3 | 16.39 Billion INR | -19.33% |
| 2019 Q1 | 11.92 Billion INR | -24.12% |
| 2019 Q2 | 20.31 Billion INR | 70.45% |
| 2018 Q4 | 15.7 Billion INR | 4.56% |
| 2018 FY | 62.54 Billion INR | -2.87% |
| 2018 Q1 | 16.02 Billion INR | -1.35% |
| 2018 Q2 | 16.32 Billion INR | 1.84% |
| 2018 Q3 | 15.02 Billion INR | -7.96% |
| 2017 FY | 64.38 Billion INR | -0.73% |
| 2017 Q4 | 16.24 Billion INR | -0.94% |
| 2017 Q3 | 16.4 Billion INR | 8.63% |
| 2017 Q2 | 15.09 Billion INR | -9.26% |
| 2017 Q1 | 16.64 Billion INR | 10.59% |
| 2016 Q3 | 16.12 Billion INR | -3.48% |
| 2016 Q2 | 16.7 Billion INR | -1.63% |
| 2016 FY | 64.85 Billion INR | 3.5% |
| 2016 Q1 | 16.98 Billion INR | 4.83% |
| 2016 Q4 | 15.04 Billion INR | -6.7% |
| 2015 Q3 | 16.01 Billion INR | 5.23% |
| 2015 Q4 | 16.2 Billion INR | 1.21% |
| 2015 Q1 | 15.2 Billion INR | 0.72% |
| 2015 Q2 | 15.21 Billion INR | 0.04% |
| 2015 FY | 62.66 Billion INR | 6.0% |
| 2014 Q1 | 14.32 Billion INR | 1.87% |
| 2014 FY | 59.11 Billion INR | 18.78% |
| 2014 Q4 | 15.1 Billion INR | -0.16% |
| 2014 Q3 | 15.12 Billion INR | 4.16% |
| 2014 Q2 | 14.52 Billion INR | 1.34% |
| 2013 FY | 49.76 Billion INR | 28.34% |
| 2013 Q3 | 13.27 Billion INR | 9.64% |
| 2013 Q2 | 12.1 Billion INR | 11.33% |
| 2013 Q1 | 10.87 Billion INR | 15.49% |
| 2013 Q4 | 14.06 Billion INR | 5.96% |
| 2012 Q1 | 9.62 Billion INR | 9.82% |
| 2012 Q2 | 9.37 Billion INR | -2.55% |
| 2012 Q3 | 10.35 Billion INR | 10.46% |
| 2012 Q4 | 9.41 Billion INR | -9.07% |
| 2012 FY | 38.77 Billion INR | 14.01% |
| 2011 Q1 | 7.76 Billion INR | 9.29% |
| 2011 FY | 34.01 Billion INR | 23.08% |
| 2011 Q2 | 8.46 Billion INR | 8.94% |
| 2011 Q3 | 9.02 Billion INR | 6.71% |
| 2011 Q4 | 8.76 Billion INR | -2.97% |
| 2010 FY | 27.63 Billion INR | 7.41% |
| 2010 Q4 | 7.1 Billion INR | -5.01% |
| 2010 Q3 | 7.48 Billion INR | 10.68% |
| 2010 Q2 | 6.75 Billion INR | 7.47% |
| 2010 Q1 | 6.28 Billion INR | -3.65% |
| 2009 Q1 | 6.91 Billion INR | 11.21% |
| 2009 FY | 25.72 Billion INR | 1.65% |
| 2009 Q4 | 6.52 Billion INR | 6.1% |
| 2009 Q3 | 6.15 Billion INR | -0.37% |
| 2009 Q2 | 6.17 Billion INR | -10.66% |
| 2008 Q3 | 6.51 Billion INR | 5.18% |
| 2008 Q4 | 6.21 Billion INR | -4.66% |
| 2008 Q2 | 6.19 Billion INR | 3.91% |
| 2008 Q1 | 5.96 Billion INR | 3.71% |
| 2008 FY | 25.31 Billion INR | 14.79% |
| 2007 Q1 | 4.01 Billion INR | -36.71% |
| 2007 Q4 | 5.75 Billion INR | -21.34% |
| 2007 Q3 | 7.31 Billion INR | 63.2% |
| 2007 Q2 | 4.48 Billion INR | 11.7% |
| 2007 FY | 22.05 Billion INR | 11.94% |
| 2006 Q2 | 4.39 Billion INR | 2.82% |
| 2006 Q1 | 4.27 Billion INR | 34.34% |
| 2006 FY | 19.69 Billion INR | 88.77% |
| 2006 Q4 | 6.33 Billion INR | 36.26% |
| 2006 Q3 | 4.65 Billion INR | 5.71% |
| 2005 Q2 | 2.27 Billion INR | -13.61% |
| 2005 Q1 | 2.63 Billion INR | -23.03% |
| 2005 Q4 | 3.18 Billion INR | 40.48% |
| 2005 Q3 | 2.26 Billion INR | -0.29% |
| 2005 FY | 10.43 Billion INR | -0.17% |
| 2004 Q3 | 2.35 Billion INR | -5.44% |
| 2004 Q4 | 3.41 Billion INR | 45.14% |
| 2004 Q2 | 2.49 Billion INR | -3.45% |
| 2004 Q1 | 2.58 Billion INR | -8.04% |
| 2004 FY | 10.45 Billion INR | 20.51% |
| 2003 Q4 | 2.8 Billion INR | 33.7% |
| 2003 FY | 8.67 Billion INR | 26.35% |
| 2003 Q1 | 1.81 Billion INR | -14.68% |
| 2003 Q2 | 1.96 Billion INR | 8.16% |
| 2003 Q3 | 2.09 Billion INR | 6.86% |
| 2002 Q2 | 1.71 Billion INR | 34.01% |
| 2002 FY | 6.86 Billion INR | 46.6% |
| 2002 Q4 | 2.12 Billion INR | 21.99% |
| 2002 Q3 | 1.74 Billion INR | 1.6% |
| 2002 Q1 | 1.28 Billion INR | -10.47% |
| 2001 Q1 | 911.78 Million INR | 0.0% |
| 2001 FY | 4.68 Billion INR | 25.4% |
| 2001 Q4 | 1.43 Billion INR | 12.99% |
| 2001 Q3 | 1.26 Billion INR | 17.87% |
| 2001 Q2 | 1.07 Billion INR | 17.9% |
| 2000 FY | 3.73 Billion INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Aarey Drugs & Pharmaceuticals Limited | 14.21 Million INR | -674479.61% |
| Aarti Drugs Limited | 1.16 Billion INR | -8112.396% |
| Aarti Pharmalabs Limited | 3.07 Billion INR | -3018.592% |
| Ajanta Pharma Limited | 30.46 Billion INR | -214.739% |
| Alembic Limited | 872.45 Million INR | -10889.412% |
| Alkem Laboratories Limited | 32.83 Billion INR | -191.999% |
| Alembic Pharmaceuticals Limited | 15.86 Billion INR | -504.158% |
| AstraZeneca Pharma India Limited | 2.47 Billion INR | -3776.208% |
| Bal Pharma Limited | 555.62 Million INR | -17155.852% |
| Biofil Chemicals and Pharmaceuticals Limited | 6.82 Million INR | -1405735.777% |
| Bliss GVS Pharma Limited | 1.41 Billion INR | -6655.673% |
| Brooks Laboratories Limited | 51.18 Million INR | -187234.896% |
| Bafna Pharmaceuticals Limited | 455.58 Million INR | -20945.03% |
| Caplin Point Laboratories Limited | 2.17 Billion INR | -4309.198% |
| Divi's Laboratories Limited | 14.17 Billion INR | -576.627% |
| Eris Lifesciences Limited | 4.94 Billion INR | -1839.696% |
| Granules India Limited | 10.31 Billion INR | -829.699% |
| Ind-Swift Limited | 946.56 Million INR | -10029.024% |
| Jagsonpal Pharmaceuticals Limited | 438.55 Million INR | -21762.501% |
| J. B. Chemicals & Pharmaceuticals Limited | 14.79 Billion INR | -548.151% |
| Jubilant Pharmova Limited | 14.45 Billion INR | -563.332% |
| Kilitch Drugs (India) Limited | 412.42 Million INR | -23147.266% |
| Medicamen Biotech Limited | 335.16 Million INR | -28506.038% |
| Medico Remedies Limited | 59.67 Million INR | -160566.946% |
| Wockhardt Limited | 8.48 Billion INR | -1030.637% |
| Orchid Pharma Limited | 800.77 Million INR | -11873.211% |
| RPG Life Sciences Limited | 1.63 Billion INR | -5762.305% |
| Shilpa Medicare Limited | 3.33 Billion INR | -2775.612% |
| Sigachi Industries Limited | 579.88 Million INR | -16433.911% |
| Solara Active Pharma Sciences Limited | 2.55 Billion INR | -3653.886% |
| Unichem Laboratories Limited | 6.72 Billion INR | -1325.511% |
| Vaishali Pharma Limited | 84.02 Million INR | -114001.084% |
| Wanbury Limited | 978.96 Million INR | -9693.803% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 23.427% |
| FDC Limited | 3.49 Billion INR | -2639.561% |
| Amrutanjan Health Care Limited | 2.09 Billion INR | -4478.62% |
| Bajaj HealthCare Limited | 985.34 Million INR | -9630.399% |
| Glenmark Life Sciences Limited | 11.64 Billion INR | -723.645% |
| Ind-Swift Laboratories Limited | 2.12 Billion INR | -4413.639% |
| Laurus Labs Limited | 11.9 Billion INR | -705.035% |
| Mangalam Drugs & Organics Limited | 162.22 Million INR | -59000.772% |
| Nectar Lifesciences Limited | 932.7 Million INR | -10179.618% |
| Par Drugs and Chemicals Limited | 58.28 Million INR | -164390.064% |
| Hester Biosciences Limited | 908.84 Million INR | -10449.492% |
| Ipca Laboratories Limited | 18.98 Billion INR | -404.951% |
| Venus Remedies Limited | 1.91 Billion INR | -4903.329% |
| ZIM Laboratories Limited | 1.01 Billion INR | -9364.216% |
| Aurobindo Pharma Limited | 55.65 Billion INR | -72.263% |
| Morepen Laboratories Limited | 1.98 Billion INR | -4724.172% |
| Neuland Laboratories Limited | 2.92 Billion INR | -3172.57% |
| Sequent Scientific Limited | 2.9 Billion INR | -3204.076% |
| Suven Pharmaceuticals Limited | 1.4 Billion INR | -6734.813% |
| Valiant Laboratories Limited | 138.02 Million INR | -69362.214% |
| Windlas Biotech Limited | 1 Billion INR | -9425.787% |
| Hikal Limited | 4.46 Billion INR | -2047.901% |
| Innova Captab Limited | 931.03 Million INR | -10198.057% |
| Procter & Gamble Health Limited | 2.99 Billion INR | -3100.841% |
| Themis Medicare Limited | 1.12 Billion INR | -8416.448% |
| IOL Chemicals and Pharmaceuticals Limited | 2.2 Billion INR | -4256.111% |
| Mankind Pharma Limited | 29.27 Billion INR | -227.532% |
| Glenmark Pharmaceuticals Limited | 46.95 Billion INR | -104.202% |
| Sakar Healthcare Limited | 204.07 Million INR | -46880.826% |
| Albert David Limited | 1.02 Billion INR | -9243.496% |
| Lupin Limited | 125.09 Billion INR | 23.356% |
| Gufic Biosciences Limited | 1.18 Billion INR | -7980.136% |
| Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 37.815% |
| Lincoln Pharmaceuticals Limited | 1.07 Billion INR | -8825.642% |
| Syncom Formulations (India) Limited | 345.63 Million INR | -27639.828% |
| Piramal Enterprises Limited | 63.65 Billion INR | -50.627% |
| Torrent Pharmaceuticals Limited | 21.42 Billion INR | -347.566% |
| NATCO Pharma Limited | 10.05 Billion INR | -853.251% |
| Suven Life Sciences Limited | 109.75 Million INR | -87260.364% |
| Krebs Biochemicals & Industries Limited | 46.15 Million INR | -207625.973% |
| Strides Pharma Science Limited | 9.16 Billion INR | -946.44% |
| Indoco Remedies Limited | 12.06 Billion INR | -694.929% |
| Alpa Laboratories Limited | 127.38 Million INR | -75169.273% |
| Lasa Supergenerics Limited | 291.17 Million INR | -32828.077% |
| Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | -3016.16% |